Drug Information: A Guide for Pharmacists, 7e

Patrick M. Malone, Benjamin A. Witt, Meghan J. Malone, David M. Peterson

Autosuggest Results

• Chapter One: Introduction to the Concept of Drug Information
• Chapter Two: Formulating an Effective Response: A Structured Approach
• Chapter Three: Drug Information Resources
• Chapter Four: Drug Literature Evaluation I: Controlled Clinical Trial Evaluation
• Chapter Five: Drug Literature Evaluation II: Beyond the Randomized Controlled Trial
• Chapter Six: The Application of Statistical Analysis in the Biomedical Sciences
• Chapter Seven: Pharmacoeconomics
• Chapter Eight: Evidence-Based Clinical Practice Guidelines
• Chapter Nine: Journal Clubs
• Chapter Ten: Peer Review
• Chapter Eleven: Legal Aspects of Drug Information
• Chapter Twelve: Ethical Aspects of Drug Information Practice
• Chapter Thirteen: Professional Communication of Drug Information
• Chapter Fourteen: Media Relations
• Chapter Fifteen: Pharmacy and Therapeutics Committee
• Chapter Sixteen: Drug Evaluation Monographs
• Chapter Seventeen: Drug Shortages and Counterfeit Drugs
• Chapter Eighteen: Quality Improvement and the Medication Use System
• Chapter Nineteen: Medication Safety I: Adverse Drug Reactions
• Chapter Twenty: Medication Safety II: Medication Errors
• Chapter Twenty-One: Policy, Procedure, and Guideline Development
• Chapter Twenty-Two: Project Management
• Chapter Twenty-Three: Investigational Drugs
• Chapter Twenty-Four: Regulatory Affairs and Pharmaceutical Industry
• Chapter Twenty-Five: Assessing Drug Promotions
• Chapter Twenty-Six: Drug Information in Ambulatory Care
• Chapter Twenty-Seven: Drug Information and Contemporary Community Pharmacy Practice
• Chapter Twenty-Eight: Pharmacy Informatics I: Systems and Technology for Patient Care
• Chapter Twenty-Nine: Pharmacy Informatics II: Big Data
• Chapter Thirty: Drug Information Education and Training
• Appendices
• Glossary
• Case Study Answers
• Abbreviations
• Answers for Self-Assessment Questions